The NIH has frozen payments to international research groups, significantly impacting funding for biomedical projects worldwide, particularly in fields like cancer and genetics. This decision, driven by concerns over transparency and potential threats to national security, will affect up to $500 million in funding annually. The NIH now mandates contracts with foreign groups to be signed directly with the agency rather than through U.S. scientists, complicating collaborations especially with institutions in China. Many researchers are left with uncertainty as they wait for clarification on funding and future regulations.
The NIH halted payments to international research groups due to transparency concerns, impacting multi-million-dollar projects across various biomedical fields globally.
The agency has imposed a new requirement for foreign groups to sign contracts directly with the NIH, complicating existing collaborations and halting funding.
NIH's leadership cited national security as a reason for suspending overseas payments, particularly in light of past collaborations with Chinese institutions like the Wuhan laboratory.
Researchers express frustration and uncertainty, with many projects on hold without clear communication from the NIH about funding status or future regulations.
Collection
[
|
...
]